Home
About
Overview
Sharing Data
ORCID
Help
History (2)
STING pathway agonism as a cancer therapeutic.
The host STING pathway at the interface of cancer and immunity.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
STING pathway agonism as a cancer therapeutic.
STING pathway agonism as a cancer therapeutic. Immunol Rev. 2019 07; 290(1):24-38.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Biomarkers
Combined Modality Therapy
DNA-Binding Proteins
Drug Evaluation, Preclinical
Humans
Immunomodulation
Membrane Proteins
Neoplasms
Signal Transduction
Treatment Outcome
authors with profiles
Thomas F. Gajewski